Glatopa (glatiramer acetate injection) for the Treatment of Multiple Sclerosis

Glatopa (glatiramer acetate injection, formerly M356) is the first substitutable generic drug approved for the treatment of relapsing-remitting multiple sclerosis (RRMS).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news